Week 542 Review

A nice positive week for Christmas. Very little happened, but most of it was positive. The deficit between cost and value narrowed by £1,204 to £145,167, and the deficit between injection and value decreased to £63,357. Total portfolio value went up to £116,511.

Only big loser was PBX:Probiotix Health which dropped 0.5p which is 7%. A continued drift downwards after spiking briefly a few months ago.

SBTX:SkinBioTherapeutics recovered from recent drops to go up 8% but is still a long way down.

Share of the Week is PAF:Pan African Resources, which also climbed 8% but has now gone 296% up. My biggest ever profit margin for a share. I slightly regret taking some profits, but I did it to spread my gold risk to some other holdings, most of which are also doing well. I don't want to sell any more.

Here's the ISA and shares portfolio after week 22 of year 11.

			Weekly Change
Cash	£177.12		+£50.00
Portfolio cost	£116,758.09		+£0
Portfolio sell value (bid price-commission)	£34,439.12	(-70.5%)	+£110.18
Potential profits	£239.45		+£46.47
Yr 11 Dividends	£69.36		+£0
Yr 11 Interest	£0.75		+£0
Yr 11 Profit from sales	£487.56		+£0
Yr 11 proj avg monthly profit	£102.05	(1.4%)	-£4.86
Total Dividends	£12,557.43		+£0
Total Interest	£9.32		+£0
Total Profit from sales	£18,047.83		+£0
Average monthly cash profit	£239.92	(3.3%)	-£0.45
(Sold stocks profit + Dividends - Fees / Months)

The rise in SBTX:SkinBioTherapeutics countered the drop in PBX:Probiotix Health and all three profitable shares went up a little, but most things remained flat, so very little change in value. Cash went up £50 thanks to an injection to my share account to cover fees.

Flat.

Still pretty much on the trend line.

The SIPP looks like this after week 526 overall and week 6 of year 11.

			Weekly Change
Cash	£998.63		+£121.50
Portfolio cost	£143,804.05		+£0
Portfolio sell value (bid price - commission)	£80,955.61	(-43.7%)	+£1,094.74
Potential profits	£11,650.85		+£1,170.97
Yr 11 Dividends	£273.10		+£0
Yr 11 Interest	£0		+£0
Yr 11 Profit from sales	£\800.74		-£0
Yr 11 proj avg monthly profit	£913.22	(9.9%)	-£152.21
Total Dividends	£18,493.30		+£0
Total Interest	£20.70		+£0
Total Profit from sales	£25,467.25		+£0
Average monthly cash profit	£348.81	(4.5%)	-£0.66

Cash went up £121 thanks to tax rebates, and most magic formula shares went up so both value and potential profits went up by just over £1,000. Nothing else happened.

Is it my imagination or is the gap to injection actually narrowing?

A satisfying gap above the trend line.

I guess it was inevitable that the trend line would catch up at some point. It was always going to be difficult to maintain that performance. I don't want to sell good shares to try and maintain the rise. JLP:Jubilee Metals could fix that if they just sort themselves out.

I've transferred £2,300 out of my work pension into my SIPP which should arrive either next week or more likely the week after. Currently I'm planning on buying HSX:Hiscox and MGNS:Morgan Sindall to add to my magic formula collection, unless either spikes before then.

Week 541 Review - Great week for the SIPP, flat for the ISA.

A good week for my SIPP, and a flat week for my ISA. A mini Santa Rally saw the deficit between cost and value narrow by £1,299 to £146,372 and the deficit between injection and value reduce to £64,625. Total portfolio value increased to £115,194.

Worst performer was AFC:AFC Energy which dropped 9%, which I suspect was profit taking after the recent big rise. Unfortunately my holding is now back to 32% down making a £667 loss.

TRU:Trufin dropped 5% for no clear reason and my holding is now only 5% up making £48 potential profit.

It was all good news after that.

BOKU:Boku had slid into loss over the last few weeks, but went up 5% and is just in profit by £4.

III:3i Group was a new purchase last week and went up 5% to go 7p into profit. I don't really want them to climb too quickly as I have another 4 months of buying with my monthly investment.

INVP:Investec had slid a bit recently but recovered 5% to go just 3% down making a £37 loss.

IES:Invinity Energy announced some new projects that have been delivered and went up 6%. My recent purchase is down 17% making £52 loss but my old holding is still 90% down making £1,174 loss..

PRU:Prudential has been on a great run and climbed another 7% this week to go 17% up and making £179 potential profit.

RAT:Rathbones also went up 7% and has gone into profit by 3% making £25 potential profit.

EDV:Endeavour Mining had a good week on an increasing gold price, rising 9% and going 8% up and making £96% profit.

Share of the Week is GGP:Greatland Resources which went up 10% and is now 86% up and making £1,059 potential profit.

Here's the ISA and shares portfolio after week 21 of year 11.

			Weekly Change
Cash	£127.12		+£0
Portfolio cost	£116,758.09		+£0
Portfolio sell value (bid price-commission)	£34,328.94	(-70.6%)	-£83.51
Potential profits	£192.98		-£53.47
Yr 11 Dividends	£69.36		+£0
Yr 11 Interest	£0.75		+£0
Yr 11 Profit from sales	£487.56		+£0
Yr 11 proj avg monthly profit	£106.91	(1.5%)	-£5.34
Total Dividends	£12,557.43		+£0
Total Interest	£9.32		+£0
Total Profit from sales	£18,047.83		+£0
Average monthly cash profit	£240.37	(3.3%)	-£0.44
(Sold stocks profit + Dividends - Fees / Months)

Virtually nothing happened. All my big holdings were flat and the £53 drop in potential profits was all TRU:Trufin.

Sticking to that pesky trend line.

The SIPP looks like this after week 525 overall and week 5 of year 11.

			Weekly Change
Cash	£877.13		+£74.23
Portfolio cost	£143,804.05		+£0
Portfolio sell value (bid price - commission)	£79,860.87	(-44.5%)	+£1,382.60
Potential profits	£10,479.88		+£1,043.42
Yr 11 Dividends	£273.10		+£74.23
Yr 11 Interest	£0		+£0
Yr 11 Profit from sales	£800.74		+£0
Yr 11 proj avg monthly profit	£913.22	(11.8%)	-£147.89
Total Dividends	£18,493.30		+£74.23
Total Interest	£20.70		+£0
Total Profit from sales	£25,467.25		+£0
Average monthly cash profit	£349.47	(4.5%)	-£0.06

Cash went up £74 thanks to a £32 dividend from N91:Ninety One, £13 from SCT:Softcat and £18 from YU.:Yu Group. Most of the £1,382 rise was in profitable shares, so potential profits increased by £1,043, and having those dividends is helping maintain my long term performance. It would be great to get to a stage where I have enough dividend-paying shares to have 4.5% return without needing to sell anything.

The gap to injection is narrowing. It would be so good to cross that line.

A definite tick up above the trend line.

Still just above the trend line but it's catching up.

Nice to have a positive week just before Christmas. There will be a few trading days next week so lets hope it continues.

Week 540 Review - Record deficit between cost and value a poor Christmas present

A pretty bad week across much of the portfolio, and a new record low. Thankfully some decent rises offset the big drops in some of my key holdings. The deficit between cost and value widened by £584 to a new high of £147,671, and the deficit between injection and value rose to £65,998. Total portfolio value fell to £113,820.

The worst performer was my largest holding OPTI:Optibiotix, which dropped 1p and lost over £2,000  in value, so the fact the weekly drop was only £584 shows how well some other shares did.

SBTX:SkinBioTherapeutics is another of my biggest holdings and dropped 12% probably due to one large shareholder having sold out.

ALU:Alumasc Group dropped 8% for no reason but my holding is still 20% up overall. They have had a pretty massive fall over the last few months, with shareholders worried about increasing costs and potentially smaller profits. I've re-calculated my magic formula rankings based on their recent performance and they drop to 28th, but that's still in the top 50, so I'll only sell if they drop outside that.

AMP:Ampeak Energy dropped 7% for no obvious reason.

FDM:FDM Group continue to slide after I thought they were staging a recovery, but they fell 6% this week to go 60% down.

POLR:Polar Capital were having a great run, but it seems to be over, with a drop of 5% this week leaving my holding only just in the black.

AMRQ:Amaroq released amazing drilling results, but only managed to climb 5%, but that was enough to put my SIPP holding back into profit and my ISA holding is 14% up.

TLOU:Tlou Energy continue to yo-yo and went up 6% this week.

TRU:Trufin climbed 6% and are now 10% up in my ISA.

AFC:AFC Energy continue to surge, with another 7% gain this week leaving my holding only down 26%.

FXPO:Ferrexpo is another yo-yo stock that would be great for trading. They went up 8% this week so my holding is now 85% down.

GGP:Greatland Resources had a splendid week, climbing 13% to go 69% up overall.

Share of the Week is PBX:Probiotix Health which went up 17% and is now 66% down. I suspect that the person selling a big chunk of SBTX:SkinBioTherapeutics may have put it here and caused a short term blip, as there's no sign of longer term price support.

Here's the ISA and shares portfolio after week 20 of year 11.

			Weekly Change
Cash	£127.12		+£40.01
Portfolio cost	£116,758.09		+£0
Portfolio sell value (bid price-commission)	£34,412.45	(-70.5%)	-£378.99
Potential profits	£246.45		+£128.94
Yr 11 Dividends	£69.36		+£44.04
Yr 11 Interest	£0.75		+£0
Yr 11 Profit from sales	£487.56		+£0
Yr 11 proj avg monthly profit	£112.25	(1.5%)	+£3.21
Total Dividends	£12,557.43		+£44.04
Total Interest	£9.32		+£0
Total Profit from sales	£18,047.83		+£0
Average monthly cash profit	£240.81	(3.3%)	-£0.13
(Sold stocks profit + Dividends - Fees / Months)

I got a £44 dividend from ASHM:Ashmore Group minus monthly fees from AJ Bell. Potential profits are up £128 thanks to AMRQ:Amaroq and TRU:Trufin both having good weeks and despite BOKU:Boku sliding to a loss. The drop in portfolio value was pretty small all things considered.

Not the bounce I was hoping for as we lead into Christmas

Staying on the trend line

The SIPP looks like this after week 524 overall and week 4 of year 11.

			Weekly Change
Cash	£802.90		-£547.47
Portfolio cost	£143,804.05		+£707.67
Portfolio sell value (bid price - commission)	£78,478.27	(-45.4%)	-£205.29
Potential profits	£9,436.46		+£525.56
Yr 11 Dividends	£198.87		+£163.67
Yr 11 Interest	£0		+£0
Yr 11 Profit from sales	£800.74		+£0
Yr 11 proj avg monthly profit	£1,061.11	(13.7%)	-£122.30
Total Dividends	£18,419.07		+£163.67
Total Interest	£20.70		+£0
Total Profit from sales	£25,467.25		+£0
Average monthly cash profit	£349.53	(4.5%)	+£0.66

I did my monthly investments. First I continued buying RAT:Rathbones. I bought 13 shares at 1821p costing £239.41. Unfortunately they promptly dropped to 1780p so my timing wasn't great. I have one more month of buying RAT.

Next I added to my position in SCT:Softcat as I think the recent drop is unjustified. I bought 17 shares at 1423.9255p costing £244.78. I'll buy more next month if they continue to remain depressed.

Finally I bought back into III:3i Group after their recent share price collapse, as I think it was over-done. It does however mean I was right to sell them when I suspected they were over valued. I bought 7 shares at 3155.497p costing £223.48.

I had an impressive £163 in dividends, made up of £49 from JHD:James Halstead, £12 from KNOS:Kainos Group and £102 from PAF:Pan African Resources.

Potential profits went up by £525 because many profitable shares had a good week, and that reduced the losses from the big fallers to just £205.

The gap to injection has been remarkably constant, but isn't improving.

Fractionally above the trend line

Again just above the trend line.

If there's going to be a Santa rally then it needs to be next week, but I can't see where it's going to come from. I only have enough cash in my SIPP to do one more month of multiple regular investments. I'd love to be able to boost that pot before 10th February else I'll have to go back to just the one monthly purchase from my regular savings.

News came through that my DDDD:4D Pharma shares are officially worthless and they have been cancelled. I was holding out a tiny hope they'd get something for selling the IP, but it at least ends the chapter of my worst ever investment, losing £18,600. That disaster is going to impact my performance for a long time to come, and I know it won't be the last as TRX:Tissue Regenix will be dead very soon, as will KIBO:Kibo Energy, and between them they will lose me £6,000. If OPTI:Optibiotix goes bust then I may as well give up.

Week 539 Review - A down week overall although SIPP up slightly.

A down week due to a big drop in the ISA, although the SIPP was in the black. The deficit between cost and value widened by £483 to £147,087 and the deficit between injection and value widened to £65,614. Total portfolio value dropped to £114,204.

Worst performer was IPX:Impax Asset Management which dropped 14% after final results. I don't understand, as the share price was massively hammered when they lost the St James's Place contract, and the figures were based on no longer having that contract, so they have been hammered twice for the same news. My main holding is now down 67% and my recent purchase is already down 22%.

SBTX:SkinBioTherapeutics results were predictably hopeless and the share price dropped by 11% back to where it was before a recent steady climb.

TLOU:Tlou Energy dropped 10% in the usual massive yo-yo.

BOKU:Boku dropped 8% for no obvious reason and have now slipped to a 2% loss.

PAF:Pan African Resources had a good week, climbing 6% to go 247% up.

GGP:Greatland Resources also had a good week, climbing 8% to go 49% up.

Share of the week is AFC:AFC Energy which climbed 10% and my holding is now only 37% down, which is significantly better than just a few weeks ago. A respected pundit has tipped them as a potential 10-bagger which helped. I hope he's right.

Here's the ISA and shares portfolio after week 19 of year 11.

			Weekly Change
Cash	£87.11		-£3.75
Portfolio cost	£116,758.09		+£0
Portfolio sell value (bid price-commission)	£34,791.44	(-70.2%)	-£919.49
Potential profits	£117.51		-£81.38
Yr 11 Dividends	£25.32		+£0
Yr 11 Interest	£0.75		+£0
Yr 11 Profit from sales	£487.56		+£0
Yr 11 proj avg monthly profit	£109.04	(1.5%)	-£6.96
Total Dividends	£12,513.39		+£0
Total Interest	£9.32		+£0
Total Profit from sales	£18,047.83		+£0
Average monthly cash profit	£240.94	(3.3%)	-£0.47
(Sold stocks profit + Dividends - Fees / Months)

Cash went down due to ISA fees, and big drop in value thanks to JLP:Jubilee Metals and SBTX:SkinBioTherapeutics.  With none of my profitable shares increasing and BOKU:Boku having a big drop, potential profits fell by £81.

The slide continues

Sticking with that trend line

The SIPP looks like this after week 523 overall and week 3 of year 11.

			Weekly Change
Cash	£1,350.37		+£233.34
Portfolio cost	£143,096.38		+£0
Portfolio sell value (bid price - commission)	£77,975.89	(-45.5%)	+£436.00
Potential profits	£8,910.90		+£1,009.88
Yr 11 Dividends	£35.20		+£0
Yr 11 Interest	£0		+£0
Yr 11 Profit from sales	£800.74		+£0
Yr 11 proj avg monthly profit	£1,183.21	(15.3%)	-£627.80
Total Dividends	£18,255.40		+£0
Total Interest	£20.70		+£0
Total Profit from sales	£25,467.25		+£0
Average monthly cash profit	£348.87	(4.5%)	-£0.80

Cash increased due to the arrival of my £250 monthly investment money, minus monthly SIPP fees. Value increased by £436 despite some big drops, and potential profits went up by over £1,000 thanks to a 4% rise in CAML:Central Asia Metals, 4% for KNOS:Kainos Group and the big rises in GGP:Greatland Resources and PAF:Pan African Resources.

Year 11 projected performance is skewed by last week's sale, so will drop dramatically over the next few weeks. TRX:Tissue Regenix announced they are de-listing and granting an epic number of shares to an existing investor to bail them out, which will make my shares utterly worthless. I'll lose £3,437 which will hammer my year 11 and long term performance, so I really need to sell enough to make £2,600 profit to balance out the loss for year 11. I'm reluctant to lose some of my more profitable shares though, so I may just take the hit for now and hope JLP:Jubilee Metals sorts itself out so I can plug the gap.

Great to see that gap closing, but very slowly.

Just above the trend line.

This is going to be ruined when I recognise the TRX:Tissue Regenix loss.

So, this first week in December has failed to deliver a Santa rally as my portfolio has dropped in value. At the moment I can't see where any rally is going to come from, as my biggest holdings are still drifting downwards. At least CAML:Central Asia Metals is staging a bit of a recovery as that's my 4th biggest holding. RIO:Rio Tinto is my 6th biggest, and that's now in profit and sneaking up too. Unfortunately OPTI:Optibiotix, JLP:Jubilee Metals and PBX:Probiotix Health are my top 3 and they are utterly hopeless, and SBTX:SkinBioTherapeutics is 5th and that is going downwards.